Jiangsu Hengrui Medicine
600276.SS
$10.85
Share price
1.21%
Change (1 day)
10.42%
Change (1 year)
Categories
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
EPS for Jiangsu Hengrui Medicine (600276.SS)
EPS in 2023 (TTM): $0.14
According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is $0.15. In 2022 the company made an earnings per share (EPS) of $0.15 a decrease over its 2021 EPS that were of $0.17.
EPS history for Jiangsu Hengrui Medicine from 2002 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $0.14 | -5.8% |
| 2022 | $0.15 | -17.1% |
| 2021 | $0.17 | -24.44% |
| 2020 | $0.23 | 20.3% |
| 2019 | $0.19 | 25.58% |
| 2018 | $0.15 | 27.55% |
| 2017 | $0.12 | 21.64% |
| 2016 | $0.09881 | 13.57% |
| 2015 | $0.08700 | 39.86% |
| 2014 | $0.06220 | 21.33% |
| 2013 | $0.05127 | 17.7% |
| 2012 | $0.04356 | 25.56% |
| 2011 | $0.03469 | 26.22% |
| 2010 | $0.02748 | 10.3% |
| 2009 | $0.02492 | 57.92% |
| 2008 | $0.01578 | 11.06% |
| 2007 | $0.01421 | 85.81% |
| 2006 | $0.007646 | 87.94% |
| 2005 | $0.004068 | 33.97% |
| 2004 | $0.003037 | 29.78% |
| 2003 | $0.002340 | 19.78% |
| 2002 | $0.001953 |